Clinical trials sponsored by Suzhou Zelgen Biopharmaceuticals Co.,Ltd
7
Recruiting trials
5
Conditions studied
Phase breakdown
Phase 1 6Phase 2 4Phase 3 1
Conditions studied
| Condition | Trials |
|---|---|
| Lung cancer | 7 |
| Small Cell Lung Cancer | 5 |
| Neuroendocrine Carcinoma | 2 |
| Advanced Solid Tumor | 1 |
| Neuroendocrine Cancer | 1 |
Recruiting trials led by Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
- Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
- Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
- Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
- Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer
- Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
- Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
Common questions
How many trials is Suzhou Zelgen Biopharmaceuticals Co.,Ltd recruiting for?
Suzhou Zelgen Biopharmaceuticals Co.,Ltd is the lead sponsor of 7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.